layoffs

Merck & Co. Eliminating 500 U.S. Sales, Commercial Jobs
Merck & Co. Eliminating 500 U.S. Sales, Commercial Jobs
Genetic Engineering News
Merck
layoffs
drug reps
Flag link:
Takeda pares down products and jobs, revives Genzyme building plans
Takeda pares down products and jobs, revives Genzyme building plans
Bizjournals
Takeda
Shire
M&A
layoffs
Flag link:
Eli Lilly to shutter neuroscience R&D center next year
Eli Lilly to shutter neuroscience R&D center next year
Fierce Biotech
Eli Lilly
UK
layoffs
R&D
Flag link:
Five Prime's new CEO wields ax, laying off 70 staffers
Five Prime's new CEO wields ax, laying off 70 staffers
Fierce Biotech
Five Prime Therapeutics
layoffs
Flag link:
Recent Job Cuts in the Biopharma Industry
Recent Job Cuts in the Biopharma Industry
BioSpace
Tocagen
Sanofi
Amneal
Daiichi Sankyo
Integra Life Sciences
Aclaris
Bayer
Novartis
Illumina
Merck
Roche Molecular Systems
Prometheus Labs
layoffs
Flag link:
Dynavax continues to shed staffers as CSO to leave with no replacement plan
Dynavax continues to shed staffers as CSO to leave with no replacement plan
Fierce Biotech
Dynavax Technologies
layoffs
Flag link:
After failed cancer test, Tocagen slashes staff
After failed cancer test, Tocagen slashes staff
Fierce Biotech
Tocagen
layoffs
gene therapy
Flag link:
Potential buyers size up Novartis site as layoffs loom for 400 workers
Potential buyers size up Novartis site as layoffs loom for 400 workers
Fierce Pharma
Novartis
drug manufacturing
layoffs
Flag link:
Daiichi Sankyo to cut 69 opioid sales jobs
Daiichi Sankyo to cut 69 opioid sales jobs
Beckers Hospital Review
Daiichi Sankyo
opioids
layoffs
drug reps
Flag link:
Inovio axes staffers, cancer program to 'sharpen focus,' save cash
Inovio axes staffers, cancer program to 'sharpen focus,' save cash
Fierce Biotech
Inovio
layoffs
bladder cancer
diagnostics
Flag link:
ImmunoGen cuts deep to eke out cash for mirvetuximab trial
ImmunoGen cuts deep to eke out cash for mirvetuximab trial
Fierce Biotech
Immunogen
R&D
layoffs
Flag link:
Top analyst finds a silver lining in AbbVie’s $63B Allergan buyout — but there’s a catch
Top analyst finds a silver lining in AbbVie’s $63B Allergan buyout — but there’s a catch
Endpoints
AbbVie
Allergan
M&A
R&D
layoffs
Flag link:
Conatus to Slash Staff, Consider Sale After NASH Trial Failures
Conatus to Slash Staff, Consider Sale After NASH Trial Failures
Xconomy
Conatus Pharmaceuticals
NASH
layoffs
emricasan
Flag link:
Sanofi to ax 466 jobs, step up focus on cancer, gene therapy R&D
Sanofi to ax 466 jobs, step up focus on cancer, gene therapy R&D
Fierce Biotech
Sanofi
layoffs
Germany
France
R&D
immuno-oncology
gene therapy
Flag link:
Sobi to buy Novimmune R&D assets, lay off 90 staff
Sobi to buy Novimmune R&D assets, lay off 90 staff
Fierce Biotech
Sobi
Novimmune
R&D
layoffs
Flag link:
Merrimack to Lay Off Remaining Execs and Staff, Sell Assets
Merrimack to Lay Off Remaining Execs and Staff, Sell Assets
BioSpace
Merrimack Pharmaceuticals
layoffs
Flag link:
Troubled microbiome startup uBiome to lay off some employees, refund payments from federal insurers
Troubled microbiome startup uBiome to lay off some employees, refund payments from federal insurers
Stat
uBiome
layoffs
Flag link:
Dynavax cuts staff in retreat from cancer research
Dynavax cuts staff in retreat from cancer research
Biopharma Dive
Dynavax Technologies
layoffs
restructuring
cancer
R&D
Flag link:
Merck plans to shed facilities, cut jobs in restructuring
Merck plans to shed facilities, cut jobs in restructuring
BioPharma Dive
Merck
drug manufacturing
layoffs
restructuring
Flag link:
Gilead cuts cardiopulmonary sales reps
Gilead cuts cardiopulmonary sales reps
BioCentury
Gilead Sciences
layoffs
generics
Letairis
Ranexa
Flag link:

Pages